High-Level Healthcare delegation to Italy in 2024
Danish Industry and the Royal Danish Embassy in Rome in collaboration with Healthcare Denmark are delighted to offer companies the opportunity to join a high-level Life Science delegation to Rome, Italy.
The delegation visit is an opportunity to showcase Danish strongholds and innovative solutions in both the pharmaceutical and the medical devices sector to Italian institutions and key NHS key opinion leaders. Moreover, the visit supports the transition to a more sustainable and innovative healthcare service of tomorrow.
Italy, with a population of 59 million people, has one of the best healthcare services in the world with a universal healthcare system that ensures equal access for all. Also ranked among the leading pharmaceutical centres in the world, with double-digit growth for R&D investments. In addition, Italy is an EU market leader in CDMO manufacturing value, and particularly strong within regional, mid-sized companies persistently investing in production lines and new tech solutions to increase efficiency and product quality. In particular, the country is strong within biotech and biologics while investments also focus on precision medicine and digital innovation supported by science parks and innovation hubs as well as R&D centres.
The life science industry is highly prioritised on the political agenda due to its supremacy to the Italian GDP and job market. As a result, attractive incentive schemes of grants and soft loans are made accessible for foreign companies wanting to invest. The Danish Life Science Industry in Italy has been successfully operating for years, employing more than 1,689 people in 2022 and a total turnover of 778 million euro.
Italy is facing a significant challenge due to an ageing population and the prevalence of multiple chronic conditions, which will require more resources in the coming years and the reorganisation of healthcare services and proximity of care. The Italian NHS, with the National Recovery and Resilience Plan, is investing in the reorganization and modernization of healthcare services to increase efficiency and treatments. These measures include the digitalization of public healthcare services, the enhanced use of healthcare data, as well as the procurement of high-tech equipment and services i.e. patient-centred treatment, outpatient care and remote patient monitoring.
Why join?
- Be part of a Danish-Italian institutional symposium in strengthening health diplomacy and cross boarder collaborations.
- Meet high-level Italian NHS decision makers and healthcare authorities.
- Gain insights into the healthcare demands and challenges.
- Opportunity to promote Danish world-class solutions.
- Explore new business opportunities and inspire public-private partnerships.
- Create longstanding partnerships and strategic collaborations.
Read more on the FPG
Foundation Policlinico Universitario Agostino Gemelli IRCCS
Founded in 1964, the Foundation Policlinico Universitario Agostino Gemelli IRCCS (FPG) is the largest hospital in Italy. It is a nationally and internationally renowned hospital: in 2023, it was ranked as the best Italian hospital and ranking 35th among the 250 top hospitals in the world. FPG has a total of 1581 beds and cares for approximately 95.000 in-patients each year. In the ranking of the best specialized hospitals (World best specialized hospitals 2024) published by Newsweek, in collaboration with Statista, the University Hospital foundation Agostino Gemelli IRCCS, in fact, takes seventh place overall in the world, and first in Italy for gynecology, and eighth place in the world, and first in Italy, for gastroenterology. Another Italian record is that of pneumology, first in Italy and 49th in the world. The Policlinico Gemelli Foundation is present in 11 of the 12 specialty rankings: cardiology, cardiac surgery, oncology, endocrinology, neurology, orthopedics, pediatrics and urology, as well as gynecology-obstetrics (which is included in this ranking for the first time), gastroenterology, pulmonology, drawn up by the American magazine Newsweek.
The hospital staff includes more than 5,000 employees with about 1000 physicians and more than 2,000 nurses.
It provides assistance in all clinical medical specializations and is recognized as one of the leading oncology centers in Italy and Europe.
In terms of research activity, FPG currently manages more than 110 grants by Competitive Calls for a value of €26 mln and more than 200 non-profit studies from private funders for a value of €27mln.
Tentative programme
